BGM Group Ltd. (BGM) vs Lifecore Biomedical, Inc. (LFCR)
BGM Group Ltd. and Lifecore Biomedical, Inc. are both Drug Manufacturers Specialty & Generic companies. Lifecore Biomedical, Inc. is the larger, with a market value of $162.4M against $104.6M — 1.6× the size. Lifecore Biomedical, Inc. has negative trailing earnings, so its P/E is not meaningful; BGM Group Ltd. trades at 4.0×. BGM Group Ltd. has the higher net margin (1.96% vs −37.5%) and the higher return on invested capital (0.00% vs −2.80%). Across the 15 metrics below, BGM Group Ltd. leads on 10 and Lifecore Biomedical, Inc. on 5.
Valuation
Profitability
| Metric | BGM | LFCR | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 6.54% | 26.86% | 53.94% |
| Operating margin | 0.00% | (6.89%) | 0.00% |
| Net margin | 1.96% | (37.54%) | 0.00% |
| Free cash flow margin | 0.00% | (4.24%) | 0.00% |
| Return on equity | 0.00% | 201.15% | (0.40%) |
| Return on assets | 0.00% | (19.32%) | (3.32%) |
| Return on invested capital | 0.00% | (2.80%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack